Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study.

Chin Med J (Engl)

Department of Hematology, Multiple Myeloma Research Center of Beijing, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

Published: July 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382319	PMC
http://dx.doi.org/10.1097/CM9.0000000000001678	DOI Listing

Publication Analysis

autologous peripheral

peripheral blood

blood stem

stem cell

cell transplantation

transplantation front-line

front-line therapy

therapy myeloma

myeloma double-hit

double-hit triple-hit

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!